Literature DB >> 19574648

Production, purification and preliminary X-ray crystallographic studies of adeno-associated virus serotype 9.

Matthew Mitchell1, Hyun-Joo Nam, Adam Carter, Angela McCall, Chelsea Rence, Antonette Bennett, Brittney Gurda, Robert McKenna, Mark Porter, Yoshihisa Sakai, Barry J Byrne, Nicholas Muzyczka, George Aslanidi, Sergei Zolotukhin, Mavis Agbandje-McKenna.   

Abstract

Adeno-associated virus (AAV) serotype 9, which is under development for gene-delivery applications, shows significantly enhanced capsid-associated transduction efficiency in muscle compared with other AAV serotypes. With the aim of characterizing the structural determinants of this property, the purification, crystallization and preliminary X-ray crystallographic analyses of the AAV9 viral capsid are reported. The crystals diffracted X-rays to 2.8 A resolution using synchrotron radiation and belonged to the trigonal space group P3(2), with unit-cell parameters a = b = 251.0, c = 640.0 A. There are three complete viral capsids in the crystal unit cell. The orientation and position of the asymmetric unit capsid have been determined by molecular-replacement methods and structure determination is in progress.

Entities:  

Mesh:

Year:  2009        PMID: 19574648      PMCID: PMC2705643          DOI: 10.1107/S1744309109021460

Source DB:  PubMed          Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun        ISSN: 1744-3091


  25 in total

1.  Implementation of molecular replacement in AMoRe.

Authors:  J Navaza
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2001-09-21

2.  Production, purification and preliminary X-ray crystallographic studies of adeno-associated virus serotype 1.

Authors:  Edward B Miller; Brittney Gurda-Whitaker; Lakshmanan Govindasamy; Robert McKenna; Sergei Zolotukhin; Nicholas Muzyczka; Mavis Agbandje-McKenna
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2006-11-30

3.  Adeno-associated virus serotype 4 (AAV4) and AAV5 both require sialic acid binding for hemagglutination and efficient transduction but differ in sialic acid linkage specificity.

Authors:  N Kaludov; K E Brown; R W Walters; J Zabner; J A Chiorini
Journal:  J Virol       Date:  2001-08       Impact factor: 5.103

4.  Structure of adeno-associated virus serotype 8, a gene therapy vector.

Authors:  Hyun-Joo Nam; Michael Douglas Lane; Eric Padron; Brittney Gurda; Robert McKenna; Erik Kohlbrenner; George Aslanidi; Barry Byrne; Nicholas Muzyczka; Sergei Zolotukhin; Mavis Agbandje-McKenna
Journal:  J Virol       Date:  2007-08-29       Impact factor: 5.103

5.  Twinned crystals of adeno-associated virus serotype 3b prove suitable for structural studies.

Authors:  Thomas F Lerch; Qing Xie; Heather M Ongley; Joan Hare; Michael S Chapman
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2009-01-31

6.  Crystallization and preliminary X-ray structural studies of adeno-associated virus serotype 6.

Authors:  Qing Xie; Heather M Ongley; Joan Hare; Michael S Chapman
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2008-10-31

7.  Adeno-associated virus (AAV) serotype 9 provides global cardiac gene transfer superior to AAV1, AAV6, AAV7, and AAV8 in the mouse and rat.

Authors:  Lawrence T Bish; Kevin Morine; Meg M Sleeper; Julio Sanmiguel; Di Wu; Guangping Gao; James M Wilson; H Lee Sweeney
Journal:  Hum Gene Ther       Date:  2008-12       Impact factor: 5.695

8.  VIPERdb: a relational database for structural virology.

Authors:  Craig M Shepherd; Ian A Borelli; Gabriel Lander; Padmaja Natarajan; Vinay Siddavanahalli; Chandrajit Bajaj; John E Johnson; Charles L Brooks; Vijay S Reddy
Journal:  Nucleic Acids Res       Date:  2006-01-01       Impact factor: 16.971

9.  Recombinant adeno-associated virus type 2, 4, and 5 vectors: transduction of variant cell types and regions in the mammalian central nervous system.

Authors:  B L Davidson; C S Stein; J A Heth; I Martins; R M Kotin; T A Derksen; J Zabner; A Ghodsi; J A Chiorini
Journal:  Proc Natl Acad Sci U S A       Date:  2000-03-28       Impact factor: 11.205

Review 10.  Designer gene delivery vectors: molecular engineering and evolution of adeno-associated viral vectors for enhanced gene transfer.

Authors:  Inchan Kwon; David V Schaffer
Journal:  Pharm Res       Date:  2007-09-01       Impact factor: 4.200

View more
  14 in total

Review 1.  Adeno-associated Virus as a Mammalian DNA Vector.

Authors:  Max Salganik; Matthew L Hirsch; Richard Jude Samulski
Journal:  Microbiol Spectr       Date:  2015-08

2.  OneBac: platform for scalable and high-titer production of adeno-associated virus serotype 1-12 vectors for gene therapy.

Authors:  Mario Mietzsch; Sabrina Grasse; Catherine Zurawski; Stefan Weger; Antonette Bennett; Mavis Agbandje-McKenna; Nicholas Muzyczka; Sergei Zolotukhin; Regine Heilbronn
Journal:  Hum Gene Ther       Date:  2014-01-23       Impact factor: 5.695

3.  The structure of adeno-associated virus serotype 3B (AAV-3B): insights into receptor binding and immune evasion.

Authors:  Thomas F Lerch; Qing Xie; Michael S Chapman
Journal:  Virology       Date:  2010-05-04       Impact factor: 3.616

4.  The AAV9 receptor and its modification to improve in vivo lung gene transfer in mice.

Authors:  Christie L Bell; Luk H Vandenberghe; Peter Bell; Maria P Limberis; Guang-Ping Gao; Kim Van Vliet; Mavis Agbandje-McKenna; James M Wilson
Journal:  J Clin Invest       Date:  2011-05-16       Impact factor: 14.808

5.  Neutralizing antibodies against AAV serotypes 1, 2, 6, and 9 in sera of commonly used animal models.

Authors:  Kleopatra Rapti; Vedell Louis-Jeune; Erik Kohlbrenner; Kiyotake Ishikawa; Dennis Ladage; Sergei Zolotukhin; Roger J Hajjar; Thomas Weber
Journal:  Mol Ther       Date:  2011-09-13       Impact factor: 11.454

6.  Structural characterization of the dual glycan binding adeno-associated virus serotype 6.

Authors:  Robert Ng; Lakshmanan Govindasamy; Brittney L Gurda; Robert McKenna; Olga G Kozyreva; R Jude Samulski; Kristin N Parent; Timothy S Baker; Mavis Agbandje-McKenna
Journal:  J Virol       Date:  2010-09-22       Impact factor: 5.103

Review 7.  Recombinant AAV-directed gene therapy for type I glycogen storage diseases.

Authors:  Janice Y Chou; Brian C Mansfield
Journal:  Expert Opin Biol Ther       Date:  2011-04-20       Impact factor: 4.388

8.  Identification of the galactose binding domain of the adeno-associated virus serotype 9 capsid.

Authors:  Christie L Bell; Brittney L Gurda; Kim Van Vliet; Mavis Agbandje-McKenna; James M Wilson
Journal:  J Virol       Date:  2012-04-18       Impact factor: 5.103

Review 9.  Perspective on Adeno-Associated Virus Capsid Modification for Duchenne Muscular Dystrophy Gene Therapy.

Authors:  Michael E Nance; Dongsheng Duan
Journal:  Hum Gene Ther       Date:  2015-10-15       Impact factor: 5.695

10.  Generation and characterization of anti-Adeno-associated virus serotype 8 (AAV8) and anti-AAV9 monoclonal antibodies.

Authors:  Yu-Shan Tseng; Kim Van Vliet; Lavanya Rao; Robert McKenna; Barry J Byrne; Aravind Asokan; Mavis Agbandje-McKenna
Journal:  J Virol Methods       Date:  2016-07-14       Impact factor: 2.014

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.